Gregory Lewis
Urology · Joliet, ILNPI 1023098910
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,363 of the $2,768 with a category attached, or 85.3%. 28 manufacturers reported payments, led by Astellas Pharma US Inc at 33.9% of the total. Reporting peaked in 2021 at $951 and has fallen 86.0% since, to $134 in 2023.
Across 133 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$938
- AbbVie$275
- Antares Pharma, Inc.$255
- Myovant Sciences Inc.$224
- Johnson & Johnson$125
- Bayer$100
- plus $850 from 22 others
What the payments were for
- Food & beverage$2,36385%
- Education$34312%
- Other$632%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 40 | $938 |
| AbbVie(2 entities) | 16 | $275 |
| Antares Pharma, Inc. | 16 | $255 |
| Myovant Sciences Inc. | 7 | $224 |
| Johnson & Johnson | 8 | $125 |
| Bayer | 7 | $100 |
| AstraZeneca | 5 | $95 |
| Merck | 5 | $84 |
| Siemens Medical Solutions USA, Inc. | 1 | $68 |
| Baxter Healthcare | 1 | $63 |
| Palette Life Sciences, Inc. | 2 | $51 |
| Myriad Genetic Laboratories, Inc. | 2 | $50 |
| Procept Biorobotics Corporation | 2 | $45 |
| Coloplast | 2 | $42 |
| Dendreon Pharmaceuticals LLC | 2 | $42 |
| Blue Earth Diagnostics | 2 | $38 |
| Teleflex LLC | 2 | $34 |
| Boehringer Ingelheim | 1 | $33 |
| Boston Scientific | 2 | $30 |
| Endo Pharmaceuticals Inc. | 2 | $30 |
| Amgen | 1 | $23 |
| Ambu Inc. | 1 | $21 |
| 180 Medical, Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Convatec Inc. | 1 | $19 |
| Urogen Pharma, Inc. | 1 | $18 |
| Urovant Sciences Inc | 1 | $14 |
| Olympus America Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORGOVYX$114
How this compares
$2,768 in reported general payments places this provider in the 55th percentile of 550 urology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $11,074 |
| Rosuvastatin Calcium | 11 | $202 |
| Carvedilol | 11 | $182 |
Paid to pharmacies, not to this prescriber.
Other urology in Joliet
- Gregory AndrosJoliet$23K
- Mark BrandtPark Ridge$1.3M
- Aaron BergerChicago Ridge$583K
- Gary SteinbergChicago$529K
- Simone CrivellaroChicago$526K
- Brian HelfandChicago$517K
- Ashley RossChicago$404K
- Kevin McVarySpringfield$372K
- Richard HarrisMelrose Park$363K
- Amy KrambeckChicago$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.